|
 |
'Own brand labeling' to boost medical device industry
 |
|
| With so many medical device makers looking further afield for opportunities to expand their businesses, some have turned their attention to a supply strategy known as own brand labeling, which is said to speed up processes and improve profitability |
|
 |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| India to monitor CROs closely
|
|
| In an effort to give a conducive business environment to CROs in the country the Indian regulatory agency has released draft rules for mandatory registration of all Clinical Research Organizations (CRO) across the country |
|
|
|
|
| |
|
|
| |
| Healthcare infrastructure supports CRO growth in Asia
|
|
| Considering the opportunity and need, the expenditure on healthcare has been on the rise in the region. In addition to the government support, private players are investing a lot in setting up good healthcare infrastructure |
|
|
|
|
| |
| Vaxine trials show 1st swine flu vaccine works
|
|
| The initial results from the clinical trials of the worlds first recombinant vaccine against swine flu, developed by a small South Australian biotech company, Vaxine Pty Ltd, indicates that the vaccine is working well in humans. |
|
|
|
|
| |
| BioSpectrumAsia Top 20: Cochlear, 18
|
|
| Cochlear is one of the worlds most innovative hearing aid companies. In 2008, it had sales of $468.61 million by selling over 18,000 implants retaining a market share of 70 percent |
|
|
|
|
| |
| Asian CMOs in demand
|
|
| Asia never had it so good. MNC pharma companies are de-risking their R&D manufacturing by outsourcing it to Asian contract research and manufacturing companiesin turn effecting substantial cost savings and keeping their faith in Asian capabilities |
|
|
|
|
| More |
